Recombinant Hepatitis B Vaccine(CHO Cell) (Lanzhou Institute of Biological Products)

重组乙型肝炎疫苗(CHO细胞) (兰州生物制品研究所有限责任公司)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRecombinant Hepatitis B Vaccine(CHO Cell) (Lanzhou Institute of Biological Products)
Drug Alias Namerecombinant hepatitis B vaccine (intramuscular)
ClassificationVaccines > Development/production technology > Genetically engineered subunit vaccineVaccines > Application > Prophylactic vaccineVaccines > National Immunization Program > Immunization program vaccine(Class I)
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsHepatitis B
Approved Indications in ChinaHepatitis B
Original Approved Country/TerritoryMainland China
Original Approved Date1998/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesLanzhou Institute Of Biological Products Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesLanzhou Institute Of Biological Products Co Ltd
Inactive CompaniesN/A
Active IndicationsHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeJ07BC01
Related LinksN/A